Trial intelligence / Profile preview

Botox for Painful Neuropathies

NCT00527202Phase 4Completed

Sponsor
Hôpital Ambroise-Paré
Start
Jun 2004
Primary completion
Mar 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of botulinum toxin type A in postherpetic neuralgia (PHN), traumatic nerve injury (PNI), sponsored by Hôpital Ambroise-Paré. Started Jun 2004; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

postherpetic neuralgia (PHN)traumatic nerve injury (PNI)

Beyond the preview

Go deeper on NCT00527202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00527202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call